Navigation Links
UPMC Invests in Intelligent Infrastructure with IBM to Support Vision of Personalized Medicine
Date:9/5/2012

ARMONK, N.Y., Sept. 5, 2012 /PRNewswire/ -- UPMC, one of the nation's leading academic medical centers, today announced the renewal of its agreement with IBM (NYSE: IBM) to continue enhancing computing and storage performance and reliability. UPMC's new technology investment with IBM, valued at $120 million over the next four years, will support the healthcare system's goal of changing the way that treatments are designed for individual patients by effectively using massive volumes of patient and research data.

(Logo:  http://photos.prnewswire.com/prnh/20090416/IBMLOGO )

Under the original agreement with IBM signed in 2005, UPMC saved or avoided costs of more than $191 million over six years, eliminating the need to create a new data center and supporting UPMC's rapid growth. Under the new agreement, IBM and UPMC will continue to collaborate on the development of medical technologies that improve care and the patient experience and remain among the founding partners in the Center for Connected Medicine, a showcase for how technology can transform healthcare.

"UPMC is keenly focused on creating new models of effective and affordable care, supported by good science and smart technology. Extending our long partnership with IBM is a key part of that strategy," said Chief Information Officer Daniel Drawbaugh.

IBM worked with UPMC to design a dynamic, virtualized technology infrastructure that shortened information backup times by 20 percent and recovery times by 50 percent. IBM's expertise in storage and server virtualization allowed the re-engineered network to become more adaptable and flexible to meet expanding patient volume and data growth for UPMC's more than 20 hospitals and 400 outpatient locations. The information technology infrastructure supports UPMC's industry-leading electronic medical records system in which patient information — including tests, radiology images, allergies and medication lists — is always available to the medical team. A private cloud system also supports all mission-critical applications for UPMC, recently ranked 10th in the nation among "America's Best Hospitals" by U.S. News & World Report.

"UPMC has pioneered a new model for ensuring its information technology keeps pace with the challenging demands of healthcare," said Dan Pelino, general manager, IBM Healthcare and Life Sciences. "With a focus on flexibility to meet the constantly changing demands of this progressive integrated healthcare delivery and financing system, UPMC's technology infrastructure plays an important role in delivering the highest quality of care, safety and efficiency."

IBM Global Technology Services will provide support and services over the term of the contract. UPMC's virtualized infrastructure is built on IBM BladeCenter and Power System servers, and IBM XIV storage systems

About IBM
For more information, please visit www.ibm.com/smarterplanet 
Follow us on Twitter @IBMHealthcare or www.twitter.com/ibmhealthcare
Join in the discussion on the Smarter Healthcare LinkedIn Group
Watch our videos at www.youtube.com/ibmhealthcare

About UPMC
UPMC is a $10 billion global health enterprise with more than 55,000 employees headquartered in Pittsburgh, Pa., and is transforming health care by integrating more than 20 hospitals, 400 doctors' offices and outpatient sites, a health insurance services division, and international and commercial services. Affiliated with the University of Pittsburgh Schools of the Health Sciences, UPMC ranked No. 10 in the prestigious U.S. News & World Report annual Honor Roll of America's Best Hospitals in 2012—and No. 1 in Pennsylvania—with 15 adult specialty areas ranked for excellence. UPMC is redefining health care by using innovative science, technology and medicine to invent new models of accountable, cost-efficient and patient-centered care. For more information on how UPMC is taking medicine from where it is to where it needs to be, go to UPMC.com.

Media Contact:
Holli Haswell
hhaswell@us.ibm.com
720-396-5485


'/>"/>
SOURCE IBM
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. JumpStart Invests $250,000 in Milo Biotechnology
2. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
3. Chicago Celebrates First Informatics Week, Co-Chaired by Intelligent Medical Objects and Northwestern University
4. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
5. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual StevieĀ® Awards for Women in Business
6. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
7. Elekta President and CEO Tomas Puusepp Pledges Support in Addressing Global Cancer Challenge at World Cancer Leaders Summit in Montreal
8. Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
9. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
10. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
11. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... YORK , March 27, 2017 ... developing novel therapies for neurodegenerative diseases, including Alzheimer,s ... that its application to list the Company,s common ... approved by The NASDAQ Stock Market, a unit ... the listing, Neurotrope will ring the Opening Bell at ...
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider ... that its board of directors has amended its shareholder rights plan. The ... 2017 to March 27, 2018. The amendment was not in response to ... ... Ltd. is a China -based biopharmaceutical company that ...
(Date:3/24/2017)... VILLAGE, Calif. , March 24, 2017   ... dermatology and aesthetics company, today announced that Richard ... Officer, effective March 24.   Peterson, who brings ... succeed John Smither , who is retiring at ... Sienna in an advisory capacity. Peterson joins Sienna from ...
Breaking Biology Technology:
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
(Date:3/22/2017)... , March 21, 2017 Vigilant Solutions ... serving law enforcement agencies, announced today the appointment of ... director of public safety business development. Mr. ... enforcement experience, including a focus on the aviation transportation ... most recent position, Mr. Sheridan served as the Aviation ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
Breaking Biology News(10 mins):